Similar articles

• 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

  Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. Tsubakihara Y, et al. Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x. Ther Apher Dial. 2010. PMID: 20609178
• It's time to compare anemia management strategies in hemodialysis.

  Coyne DW. Coyne DW. Clin J Am Soc Nephrol. 2010 Apr;5(4):740-2. doi: 10.2215/CJN.02490409. Epub 2010 Mar 18. Clin J Am Soc Nephrol. 2010. PMID: 20299363
• Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan.

  Fukuma S, Yamaguchi T, Hashimoto S, Nakai S, Iseki K, Tsubakihara Y, Fukuhara S. Fukuma S, et al. Am J Kidney Dis. 2012 Jan;59(1):108-16. doi: 10.1053/j.ajkd.2011.07.014. Epub 2011 Sep 3. Am J Kidney Dis. 2012. PMID: 21890255
• Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?

  Badve SV, Hawley CM, Johnson DW. Badve SV, et al. Nephrology (Carlton). 2011 Feb;16(2):144-53. doi: 10.1111/j.1440-1797.2010.01407.x. Nephrology (Carlton). 2011. PMID: 21272125 Review.
• [Change of hemoglobin level: causes and consequences. Renal anemia].

  Ryckelynck JP. Ryckelynck JP. Nephrol Ther. 2008 Oct;4 Spec No 2:9-16. doi: 10.1016/S1769-7255(08)74251-2. Nephrol Ther. 2008. PMID: 19000893 Review. French. No abstract available.